AKAP6 | A kinase (PRKA) anchor protein 6 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ALPK2 | Alpha-kinase 2 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ATP1A3 | ATPase, Na+/K+ transporting, alpha 3 polypeptide | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
B3GALT2 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
BVES | Blood vessel epicardial substance | Predicted membrane proteins
| | | | | Tissue enhanced |
CACNA1C | Calcium channel, voltage-dependent, L type, alpha 1C subunit | Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
CDH2 | Cadherin 2, type 1, N-cadherin (neuronal) | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CLGN | Calmegin | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CRYAB | Crystallin, alpha B | Cancer-related genes Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CTAG2 | Cancer/testis antigen 2 | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CTNNA3 | Catenin (cadherin-associated protein), alpha 3 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
DPF3 | D4, zinc and double PHD fingers, family 3 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FILIP1 | Filamin A interacting protein 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
MASP1 | Mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NEBL | Nebulette | Predicted intracellular proteins
| | | | | Tissue enhanced |
NES | Nestin | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
OXCT1 | 3-oxoacid CoA transferase 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PDE3A | Phosphodiesterase 3A, cGMP-inhibited | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
PKP2 | Plakophilin 2 | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
PPFIA4 | Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
S100A1 | S100 calcium binding protein A1 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SLC2A4 | Solute carrier family 2 (facilitated glucose transporter), member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SMYD1 | SET and MYND domain containing 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
TCF15 | Transcription factor 15 (basic helix-loop-helix) | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |